FWL Investment Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.53M Sell
32,316
-173,774
-84% -$14M 0.46% 45
2026
Q1
$17.9M Buy
206,090
+100,191
+95% +$9.6M 3.92% 7
2025
Q4
$10.2M Buy
105,899
+10,301
+11% +$1M 2.45% 18
2025
Q3
$9.1M Buy
95,598
+41,186
+76% +$3.79M 2.37% 19
2025
Q2
$4.74M Buy
54,412
+13,448
+33% +$1.14M 1.45% 22
2025
Q1
$3.68M Buy
+40,964
New +$3.67M 1.37% 24
2024
Q4
Sell
-100
Closed -$9K 321
2024
Q3
$9K Buy
+100
New +$8.41K ﹤0.01% 243

Other funds holding MDT

FWL Investment Management's MDT Position: Q2 2026 in Review

FWL Investment Management reduced its Medtronic (MDT) stake by 84% in Q2 2026, selling an estimated $14M and leaving 32,316 shares worth $2.53M. The position accounts for 0.46% of the portfolio, ranked #45.

FWL Investment Management first reported a position in MDT in Q3 2024 and has held it in 7 quarters since. The position peaked at $17.9M in Q1 2026. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • FWL Investment Management held 32,316 shares of Medtronic worth $2.53M as of Q2 2026.
  • FWL Investment Management sold 173,774 Medtronic shares in Q2 2026, an estimated $14M.
  • Medtronic made up 0.46% of FWL Investment Management's portfolio in Q2 2026, its #45 holding.
  • FWL Investment Management first reported a position in Medtronic in Q3 2024 and has held it in 7 quarters since.
  • FWL Investment Management's Medtronic position peaked at $17.9M in Q1 2026.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on FWL Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.